Definium Therapeutics engages at Fierce Biotech Week with industry communications leaders

Definium Therapeutics engages at Fierce Biotech Week with industry communications leaders
Definium joins biotech panel event

Definium Therapeutics is participating in Fierce Biotech Week, with its Chief Corporate Affairs Officer, Stephanie Fagan, taking part in a panel discussion.

She is joined by Debbie Etchison, Executive Director and Head of Corporate Affairs at Alkeus Pharmaceuticals, and Madeleine Shin, Executive Director and Global Head of External Communications and Media at another leading organization. The session focuses on corporate communications strategies within the biotechnology sector. Further details on the panel and key takeaways from their discussion are expected soon.

Definium Therapeutics recently hosted an Investor and Analyst Day in New York City to update stakeholders on its progress in psychedelic treatment development. The company has also scheduled a live webcast to announce Q1 2026 financial results on May 7. These events highlight continued engagement with investors and analysts alongside industry activities like Fierce Biotech Week.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.